Long-term efficacy and safety of ustekinumab, with
and without dosing adjustment, in patients with
moderate-to-severe psoriasis: results from the PHOENIX 2
study through 5 years of follow-up
in this study what is meant by PHOENIX 1 and PHOENIX 2 study?